Search

Latest News & Views in Diabetes Technology

New diabetes tech products, enhancements, best practices, resources and more 

  • How CGM Data Could Revolutionize Diabetes Complications Prediction

    Feb 11, 2025
    New research from the University of Virginia Center for Diabetes Technology highlights that data from continuous glucose monitors (CGMs) can be as effective as hemoglobin A1c levels in predicting long-term diabetes complications. The study found that keeping glucose levels within a safe range over 14 days can indicate risks for nerve, eye, and kidney damage, potentially reshaping how healthcare providers assess and prevent complications in individuals with type 1 diabetes.

  • 5 Key Diabetes Tech Takeaways from ADA's Updated Standards of Care

    Jan 6, 2025
    The American Diabetes Association (ADA) recently released its Standards of Care in Diabetes—2025, bringing forward significant updates that underscore the growing importance of diabetes technology in improving patient outcomes. The following highlights explore the latest advancements and recommendations, showcasing a clear shift towards broader adoption and personalization of diabetes devices.

  • SAFETY ALERT: MiniMed™ 600 series and 700 series pump systems — battery status alerts and alarms

    Oct 7, 2024
    Medtronic has issued a follow-up to their July 2024 safety alert. This update addresses potential issues with shortened battery life, which may cause insulin pumps to stop delivery sooner than expected, especially if the pump has been physically impacted (e.g., dropped or bumped). Pumps affected include pump models include the MiniMed™ 630G, 670G, 770G, and 780G systems.

  • Dexcom G7 Now Connects Directly to Apple Watch

    Jun 6, 2024
    Direct to Apple Watch is now available to Dexcom G7 users in the US, UK and Ireland. To use Direct to Apple Watch, users must have the Dexcom G7 app version 2.1, Apple Watch Series 6 or later running watchOS 10 or later, and an iPhone running iOS 17 or later.

  • Dexcom's Stelo Cleared by FDA as Over-the-Counter

    Mar 6, 2024
    Stelo by Dexcom, the first glucose biosensor cleared by the FDA for over-the-counter use, will be available in the US for individuals aged 18 and older not using insulin therapy, making it accessible without a prescription. This small, wearable sensor, worn on the upper arm, will transmit glucose data directly to the user's smartphone. Developed by Dexcom, Stelo aims to empower people with Type 2 diabetes to manage their health effectively. Available from summer 2024 onwards, Stelo fills a crucial gap in the market, providing continuous glucose monitoring for those without insurance coverage or prescription access.

The Danatech Digest

Join 18,000+ professionals who get our latest diabetes technology updates

    

DISCLAIMERS: 

This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.

ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.